| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
Stromal cell
|
Cell type |
|
|
Monocyte
|
Cell type |
|
|
PC3
|
Cell line |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Not applicable
|
Histology |
|
|
FLAP
|
Compound treatment |
|
|
Breast carcinoma
|
Disease state |
|
|
N/a
|
Test result |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
HNRPA2B
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
HL-60
|
Cell line |
|
|
Skeletal muscle
|
Organism part |
|
|
Epithelial cell
|
Cell type |
|
|
Cystic change
|
Histology |
|
|
BT-474
|
Cell line |
|
|
Huntington's disease
|
Disease state |
|
|
Dimethyl sulfoxide
|
Compound treatment |
|
|
None
|
Compound treatment |
|
|
Caudate nucleus
|
Organism part |
|
|
White blood cells
|
Organism part |
|
|
Cerebellum
|
Organism part |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Epilepsy
|
Disease state |
|
|
Heregulin
|
Compound treatment |
|
|
HPL1
|
Cell line |
|
|
Glioblastoma
|
Disease state |
|
|
Grade IV
|
Tumor grading |
|
|
CD16+ dendritic cell
|
Cell type |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
Rapamycin
|
Compound treatment |
|
|
MDA-MB-231
|
Cell line |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
T84
|
Cell line |
|
|
Caco-2
|
Cell line |
|
|
BDCA3+ dendritic cell
|
Cell type |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
SKBR3
|
Cell line |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Serum starvation synchronizati...
|
Growth condition |
|
|
Multiple myeloma
|
Disease state |
|
|
MDA468
|
Cell line |
|
|
Malignant melanoma
|
Disease state |
|
|
Term
|
Developmental stage |
|
|
Midgestation
|
Developmental stage |
|
|
Neutrophil
|
Cell type |
|
|
Endothelial cell
|
Cell type |
|
|
Ovary
|
Organism part |
|
|
Granulocyte
|
Cell type |
|
|
Homo sapiens
|
Organism |
|
|
Capra hircus
|
Organism |
|
|
GLI60
|
Cell line |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
T cell
|
Cell type |
|
|
Peripheral blood mononuclear c...
|
Cell type |
|
|
Tumor
|
Organism part |
|
|
CD8+ central memory T cell
|
Cell type |
|
|
Duchenne muscular dystrophy
|
Disease state |
|
|
CD8+ T cell
|
Cell type |
|
|
U266
|
Cell line |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
CD34+
|
Cell type |
|
|
HGF stimulation
|
Growth condition |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
Plasmacytoid dendritic cell
|
Cell type |
|
|
MCF7
|
Cell line |
|
|
MCF-7
|
Cell line |
|
|
Control for EGF
|
Compound treatment |
|
|
Lymph node
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
M2 macrophage
|
Cell type |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Clear cell sarcoma of the kidn...
|
Disease state |
|
|
Bone marrow
|
Organism part |
|
|
Hypericin incubated, not irrad...
|
Growth condition |
|
|
Hypericin incubated, irradiate...
|
Growth condition |
|
|
Whole brain
|
Organism part |
|
|
MCF10A
|
Cell line |
|
|
Control - IL-1b
|
Compound treatment |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
CD8+ effector memory RA T cell
|
Cell type |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
Vasectomized
|
Clinical history |
|
|
Native skin
|
Cell type |
|
|
Uterus corpus
|
Organism part |
|
|
Skin
|
Organism part |
|
|
Primary
|
Disease staging |
|
|
Lymph node metastasis
|
Disease staging |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
IL-4
|
Compound treatment |
|
|
Non-smoker
|
Clinical info |
|
|
Brain
|
Organism part |
|
|
Media only
|
Growth condition |
|
|
Immediately after exercise
|
Clinical info |
|
|
Cyclosporin A, mycophenolate m...
|
Clinical treatment |
|
|
Sirolimus, mycophenolate mofet...
|
Clinical treatment |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
GLI72
|
Cell line |
|
|
Wilms' tumor
|
Disease state |
|
|
Experimental malaria-infected
|
Disease state |
|
|
ITM
|
Cell line |
|
|
Baseline uninfected
|
Disease state |
|
|
Unsynchronized
|
Growth condition |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
Heart
|
Organism part |
|
|
XBP1 overexpression
|
Genotype |
|
|
2-(3,4,5-trimethoxy-phenylamin...
|
Compound treatment |
|
|
Carcinoma in situ lesion
|
Disease state |
|
|
Mononuclear cell
|
Cell type |
|
|
Appendix
|
Organism part |
|
|
Control - untreated
|
Compound treatment |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
Ewing family tumor
|
Disease state |
|
|
Neuroblastoma
|
Disease state |
|
|
KSHV infection
|
Disease state |
|
|
Seminiferous tubule
|
Organism part |
|
|
IL-22
|
Compound treatment |
|
|
Cigarette smoke
|
Growth condition |
|
|
Incubator control
|
Growth condition |
|
|
Granulocyte-colony stimulating...
|
Compound treatment |
|
|
60 min after exercise
|
Clinical info |
|
|
Obesity
|
Disease state |
|
|
Non-ischemic cardiomyopathy
|
Disease state |
|
|
Baseline sevoflurane
|
Compound treatment |
|
|
BC-3
|
Cell line |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Adipose tissue-derived stem ce...
|
Cell type |
|
|
Cingulate cortex
|
Organism part |
|
|
IL-20
|
Compound treatment |
|
|
BC-1
|
Cell line |
|
|
Pons
|
Organism part |
|
|
Filtered air
|
Compound treatment |
|
|
Keratinocyte growth factor
|
Compound treatment |
|
|
Amygdala
|
Organism part |
|
|
Occipital lobe
|
Organism part |
|
|
Subthalamic nucleus
|
Organism part |
|
|
Malignant pleural mesothelioma
|
Disease state |
|
|
CD14+ monocyte
|
Cell type |
|
|
Dendritic cell
|
Cell type |
|
|
Water
|
Compound treatment |
|
|
Cooked broccoli
|
Compound treatment |
|
|
HTERT/HPVE6/HPVE7/SV40t transf...
|
Gene modification |
|
|
Astrocytic tumor
|
Disease state |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
Ethanol
|
Vehicle |
|
|
CD19+ B-cell
|
Cell type |
|
|
Fibroblast
|
Cell type |
|
|
Uninfected
|
Infection |
|
|
Mock
|
RNAi |
|
|
PEL-5
|
Cell line |
|
|
Keratinocyte
|
Cell type |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
CD11c+ dendritic cell
|
Cell type |
|
|
NCI-H929
|
Cell line |
|
|
Crohn's disease
|
Disease state |
|
|
AdERb high moi
|
Gene modification |
|
|
DMSO
|
Vehicle |
|
|
Testis
|
Organism part |
|
|
Papillary thyroid carcinoma
|
Disease state |
|
|
Stroma from endometriotic nodu...
|
Organism part |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
GLI56
|
Cell line |
|
|
|
|
|
Processing time: 0.147 secs.